Literature DB >> 11727161

[Renal oxalosis with renal failure after infusion of xylitol].

P Leidig1, W Gerding, W Arns, M Ortmann.   

Abstract

HISTORY AND
FINDINGS: Ten days after a complication-free operation for early gastric cancer a 61-year old man had a seizure and acute renal failure. INVESTIGATIONS: A percutaneous renal biopsy was performed to find the cause of the renal failure, which at times required several sessions of haemodialysis. TREATMENT AND COURSE: The seizure was thought to have been due to cerebrovascular deposits of oxalate crystals (renocerebral oxalosis). Parenteral xylitol had been given postoperatively, as a glucose substitute (total dose 1560g), together with other routine drugs. Primary oxalosis and other causes of secondary oxalosis had been excluded.
CONCLUSION: Xylitol should not be used parenterally as a glucose substitute (banned in the USA).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11727161     DOI: 10.1055/s-2001-18650

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  4 in total

1.  Fatal cerebro-renal oxalosis after appendectomy.

Authors:  H Pfeiffer; F U Weiss; B Karger; A Aghdassi; M M Lerch; B Brinkmann
Journal:  Int J Legal Med       Date:  2003-11-22       Impact factor: 2.686

Review 2.  Metabolic and catheter complications of parenteral nutrition.

Authors:  Marwan S Ghabril; Jamie Aranda-Michel; James S Scolapio
Journal:  Curr Gastroenterol Rep       Date:  2004-08

3.  Safety assessment of inhaled xylitol in mice and healthy volunteers.

Authors:  Lakshmi Durairaj; Janice Launspach; Janet L Watt; Thomas R Businga; Joel N Kline; Peter S Thorne; Joseph Zabner
Journal:  Respir Res       Date:  2004-09-16

Review 4.  Correlation of D-xylose with severity and morbidity-related factors of COVID-19 and possible therapeutic use of D-xylose and antibiotics for COVID-19.

Authors:  Antony Cheudjeu
Journal:  Life Sci       Date:  2020-08-23       Impact factor: 5.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.